Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hero
AddedFeb 15, 2024
UpdatedJun 18, 2026
Hero

Hero

Hero: Your smart, FSA-approved pill dispenser and medication manager, tracking daily adherence.

HQ
New York City, NY, US
Founded
2018
Overview
Compare
Fundraising
Employees
News
Website

Hero's core mission is to simplify medication management through innovative technology. Their flagship product, the Hero smart pill dispenser, organizes, dispenses, and tracks medications, ensuring users adhere to their regimens. The device, about the size of a coffee maker, fits conveniently on kitchen counters and alerts users when it's time to take their pills. Complementing the dispenser is the Hero mobile app, which provides real-time adherence data and helps manage complex medication schedules. Hero is FSA/HSA approved and designed in America.

Hero has made significant strides in improving medication adherence and reducing the complexities associated with managing multiple prescriptions. By integrating a user-friendly device with a comprehensive mobile app, Hero has positively impacted the lives of individuals who require consistent medication management. The company's focus on real-time data and ease of use has garnered attention and trust from users and healthcare providers alike.

Hero - Similar Companies

PillDrill logo

PillDrill

pilldrill.com

MedMinder Systems logo

MedMinder Systems

medminder.com

AutoMedTech logo

AutoMedTech

AdhereTech logo

AdhereTech

adheretech.com

Medisafe logo

Medisafe

medisafe.com

Medsense Health logo

Medsense Health

medsense.health

TowerView Health logo

TowerView Health

Apothewell logo

Apothewell

apothewell.com

MediPocket logo

MediPocket

EllieGrid logo

EllieGrid

elliegrid.com

PharmAdva logo

PharmAdva

pharmadva.com

HealthID logo

HealthID

PatchRx logo

PatchRx

patchrx.io

Medacheck logo

Medacheck

medacheck.com

CuePath Innovation logo

CuePath Innovation

cuepath.io

Hero - Quick Facts

Who are Hero's competitors?

Companies similar to Hero include PillDrill, MedMinder Systems, AutoMedTech and AdhereTech.

When was Hero founded?

Hero was founded in 2018.

Where is Hero's headquarters located?

Hero's headquarters is located in New York City, NY, US.

When was Hero's last funding round?

Hero's most recent funding round was for $12M (USD) in October 2018.

How much has Hero raised to-date?

As of Oct 16, 2018, Hero has raised a total of $12M (USD).

How many employees does Hero have?

Hero has 443 employees as of Feb 4, 2024.

Hero - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • IoT
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Medication Management
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software